Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Baxter introduces Hyqvia in US to treat primary immunodeficiency Baxter International and Halozyme Therapeutics have launched Hyqvia as a subcutaneous immunoglobulin treatment for adult patients with primary immunodeficiency (PI) in the US. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.

Process & Production

Tribute Pharmaceuticals secures uracyst patent in Europe
Tribute Pharmaceuticals Canada has received a patent approval from the European Patent Office (EPO) for intellectual property central to one of the Company's lead products, Uracyst/Uropol (a sterile sodium chondroitin sulfate solution, 2%), for the treatment of interstitial cystitis by instillation into the bladder of a patient.
Levolta receives US patent for new investigational therapy for controlling osteoarthritis
Levolta Pharmaceuticals an emerging leader in developmental osteoarthritis (OA) therapy, has announced that the US Patent and Trademark Office has awarded the company a patent for its novel VOLT01, a derivative of zoledronic acid (ZA), a proposed commercial product that has shown promise as a disease-modifying drug in clinical trials.


SAFC introduces new protein quality supplement to increase N-linked Glycosylation
Sigma-Aldrich has announced that SAFC Commercial, its custom manufacturing services business unit, has introduced a new protein quality supplement called EX-CELL Glycosylation Adjust (Gal+).
Plandai secures approval in Uruguay to grow cannabis for medical research
Plandaí Biotechnology, a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, has announced that Uruguay's Ministry of Public Health has approved an academic collaboration between Plandaí and the Group of Medicinal Chemistry from the School of Science at the University of the Republic in Montevideo, Uruguay.


Affinivax launches new conjugate vaccine for Ggobal impact on infectious diseases
Affinivax, a biotechnology company dedicated to developing novel vaccines, has announced its launch with a $4m investment from the Bill & Melinda Gates Foundation.
Cirrus Pharmaceuticals to invest in cGMP manufacturing suite in US
Cirrus Pharmaceuticals, a Kemwell company, which is a 100% services oriented company providing pharmaceutical contract development and manufacturing services, has announced that it will be investing in a flexible cGMP suite in its facility in RTP, North Carolina.